Supplementary protection certificates and their impact on access to medicines in Europe: case studies of sofosbuvir, trastuzumab and imatinib

Overview of attention for article published in Journal of Pharmaceutical Policy and Practice, January 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#13 of 528)
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

news: 2 news outlets
blogs: 1 blog
policy: 1 policy source

twitter: 32 X users
facebook: 1 Facebook page

Citations

dimensions_citation: 24 Dimensions

Readers on

mendeley: 57 Mendeley

Summary News Blogs Policy documents X Facebook Dimensions citations

So far, Altmetric has seen 1 blog post.

Monthly Round-Up of What to Read on Pharma Law and Policy

Bill of Health, 28 Feb 2020

By Ameet Sarpatwari, Charlie Lee, Frazer Tessema, and Aaron S.

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.